Bids Are Invited For Central Purchase - Medicines Court Service Iv

Abemaciclibe Active Principle: Abemaciclib; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .; Acarbose - Active Principle: Acarbose; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Ascorbic Acid - Active Principle: Ascorbic Acid; Concentration/Dosage: 1,000 Mg; Pharmaceutical Form: Effervescent Tablet; Administration Road:, Ascorbic Acid - Active Principle: Ascorbic Acid; Concentration/Dosage: 500 Mg; Pharmaceutical Form: Tablet; Administration Route: Oral; Present, Acid Gamaminobutirical + Associations - Active Principle (1): Acid Gamaminobutirical Acid Tartarate; Active Principle (2): Glutamic Acid + Aunt Nitrate, 10/07/2025, Alfalcidol - Active Principle: Alfalcidol; Concentration/Dosage: 0, 25 Mcg; Pharmaceutical Form: Soft Gelatinous Capsule; Presentation: .; Component, Aminoados - Indication: Chronic Renal Disease; Estate Range: Adults; Composition: Essential Aminoacides; Additional: Ketoacidos; Pharmaceutical Form: C, Ornitine Aspartate - Active Principle: Ornitine Aspartate; Concentration/Dosage: 0, 6 G/G; Pharmaceutical Form: Granulated; Presentation: Envelope 5, Atenolol + Associations - Active Principle (1): Atenolol; Active Principle (2): Chloridan; Concentration/Dosage: 25 Mg + 12, 5 Mg; Pharmaceutical Form:, Bimatoprost - Active Principle: Bimatoprosta; Concentration/Dosage: 0, 3 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: 3 Ml Bottle; Compo, Briminidina - Active Principle: Briminidina, Dextrotartarato; Concentration/Dosage: 1, 5 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: Fra, Optilonium Bromide - Active Principle: Optilonium Bromide; Concentration/Dosage: 40 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Co, Pinaverio Bromide - Active Principle: Pinaverio Bromide; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Coated Tablet; Presentation:.; Concentration/Dosage: 100 Mg; Equivalence: 102 Mg Of Hemi-Hydrated Canagliflozine; Formaceut Form, Canagliflozine - Active Principle: Canagliflozine; Concentration/Dosage: 300 Mg; Equivalence: 306 Mg Hemi-Hydrated Canagliflozine; Formaceut Form, Ketotifen - Active Principle: Cetotiphene, Fumarate; Concentration/Dosage: 0, 25 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: 5 Ml Vial, Cyanocobalamin + Associations - Active Principle (1): Cyanocobalamin; Active Principle (2): Pyridoxine + Thiamine + Sodico Diclofenac; Concentration/Dos, Cinalcete - Active Principle: Cinalcete, Hydrochloride; Concentration/Dosage: 60 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Compon, Sodium Chloride - Active Principle: Sodium Chloride; Concentration/Dosage: 5%; Pharmaceutical Form: Ophthalmic Solution; Presentation: 10 Ml Vial; With, Dismapresine - Active Principle: Dismapresine, Acetate; Concentration/Dosage: 0, 1 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .; 2 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .; Deutetrabenazin - Active Principle: Deutetrabenazine; Concentration/Dosage: 12 Mg; Pharmaceutical Form: Lained Liberation Coated Tablet; Apre, Deutetrabianazine - Active Principle: Deutetrabenazine; Concentration/Dosage: 6 Mg; Pharmaceutical Form: Lained Liberation Coated Tablet; Presentation, Deutetrabnazin - Active Principle: Deutetrabenazine; Concentration/Dosage: 9 Mg; Form